Dalfampridine
Brand name: Dalfampridine Er
Rank #321 of 500 drugs by total cost
$34.1M
Total Cost
40,425
Total Claims
$34.1M
Total Cost
1,164
Prescribers
$844
Cost per Claim
3,487
Beneficiaries
52,621
30-Day Fills
$29K
Avg Cost/Provider
35
Avg Claims/Provider
About Dalfampridine
Dalfampridine (sold as Dalfampridine Er) was prescribed 40,425 times by 1,164 Medicare Part D providers in 2023, costing the program $34.1M. At $844 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 318 | Isosorbide Mononitrate (Isosorbide Mononitrate Er) | $34.5M | 1,805,114 |
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology